Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Schaffer currently holds 901,215 shares of 4D Molecular Therapeutics Inc. (FDMT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Schaffer has been a net seller of FDMT stock. They have purchased $0 and sold $3.4M worth of shares.
David Schaffer's most recent insider trade was on Oct 22, 2021, when they sold 1,900 shares at $31.00 per share.
David Schaffer serves as Executive at 4D Molecular Therapeutics Inc. (FDMT). They have executed 20 insider transactions totaling $3.4M over their tenure at the company.
David Schaffer holds the position of Executive at 4D Molecular Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
David Schaffer has shown a selling trading pattern, with $0 in total purchases and $3.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David Schaffer was on Oct 21, 2021, when they sold $720.2K worth of FDMT shares. This transaction involved 22,820 shares at $31.56 per share.
David Schaffer currently owns 901,215 shares of 4D Molecular Therapeutics Inc. (FDMT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Schaffer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Schaffer has 20 Form 4 filings on record as an insider at 4D Molecular Therapeutics Inc..
Set alerts for David Schaffer and 40,000+ other insiders.